Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionHsbc Holdings Plc
Latest Disclosed Ownership655,443 shares
Latest Disclosed Value $ 292,663,320
Hsbc Holdings Plc ownership in VRTX / Vertex Pharmaceuticals Incorporated

On April 30, 2026 - Hsbc Holdings Plc filed a 13F-HR form disclosing ownership of 655,443 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $292,681,517 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 20, 2026 disclosing 630,289 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 3.99% during the quarter. The current value of the position is $292,871,596 USD.

Hsbc Holdings Plc has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options. The firm currently holds call options representing 6,100 of underlying shares valued at $2,722,940 USD and put options representing 6,400 of underlying shares valued at $2,856,160 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 655,443 25,154 3.99 292,663 2.37 0.0204
2026-03-20 2025-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 630,289 -7,043 -1.11 285,886 14.60 0.0156
2026-03-06 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 630,289 -7,043 -1.11 285,886 14.60 0.0131
2025-11-13 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 637,332 -4,629 -0.72 249,455 -12.69 0.1376
2025-08-13 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 641,961 -202,714 -24.00 285,727 -30.07 0.1716
2025-05-14 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 844,675 -29,080 -3.33 408,562 16.16 0.2525
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 873,755 18,739 2.19 351,726 -11.50 0.2046
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 855,016 -49,726 -5.50 397,442 -6.52 0.2314
2024-08-12 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 904,742 98,800 12.26 425,144 26.22 0.2599
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 805,942 191,273 31.12 336,840 34.61 0.2280
2024-02-12 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 614,669 53,862 9.60 250,232 28.24 0.2182
2023-11-13 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 560,807 -121,386 -17.79 195,123 -18.68 0.2030
2023-08-11 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 682,193 118,878 21.10 239,944 35.27 0.2442
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 563,315 74,725 15.29 177,387 26.02 0.2125
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 488,590 176,722 56.67 140,766 54.85 0.1618
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 311,868 -18,892 -5.71 90,907 -2.44 0.1482
2022-08-11 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 330,760 -17,468 -5.02 93,178 2.96 0.1301
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 348,228 -30,985 -8.17 90,503 8.29 0.1100
2022-02-11 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 379,213 -21,846 -5.45 83,575 14.67 0.0771
2021-11-12 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 401,059 42,914 11.98 72,880 1.72 0.0734
2021-08-13 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 358,145 56,678 18.80 71,648 10.82 0.0764
2021-05-14 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 301,467 -58,268 -16.20 64,652 -23.15 0.0761
2021-02-25 2020-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 359,735 61,071 20.45 84,130 3.44 0.1121
2021-02-12 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 389,635 90,971 91,069 21,623.1280
2020-11-12 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 298,664 74,598 33.29 81,335 25.04 0.1298
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 224,066 -2,983 -1.31 65,046 21.61 0.1235
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 227,049 16,710 7.94 53,486 13.80 0.1242
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 210,339 -64,040 -23.34 47,001 1.11 0.0817
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 274,379 22,616 8.98 46,485 0.69 0.0867
2019-08-13 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 251,763 93,849 59.43 46,168 58.93 0.0877
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 157,914 12,924 8.91 29,049 22.01 0.0530
2019-02-13 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 144,990 -66,863 -31.56 23,809 -41.68 0.0440
2018-11-13 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 211,853 17,772 9.16 40,824 23.77 0.0657
2018-08-10 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 194,081 -86,920 -30.93 32,985 -27.98 0.0587
2018-05-11 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 281,001 29,050 11.53 45,798 21.30 0.0682
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 251,951 -61,476 -19.61 37,757 -20.77 0.0547
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 313,427 57,668 22.55 47,652 44.57 0.0763
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 255,759 110,408 75.96 32,961 107.29 0.0606
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 145,351 18,067 14.19 15,901 69.57 0.0332
2017-02-09 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 127,284 18,676 17.20 9,377 -0.99 0.0219
2016-11-14 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 108,608 4,288 4.11 9,471 5.54 0.0236
2016-08-12 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 104,320 -20,448 -16.39 8,974 -9.52 0.0247
2016-05-13 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 124,768 8,888 7.67 9,918 -31.98 0.0279
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 115,880 -47,648 -29.14 14,582 -14.37 0.0351
2015-11-12 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 163,528 -297,223 -64.51 17,030 -70.06 0.0429
2015-08-13 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 460,751 189,921 70.13 56,875 77.75 0.1161
2015-05-14 2015-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 270,830 22,799 9.19 31,998 8.57 0.0614
2015-02-13 2014-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 248,031 -50,455 -16.90 29,471 -12.17 0.0611
2014-11-18 2014-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 298,486 100,336 50.64 33,556 79.20 0.0702
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 198,150 15,559 8.52 18,725 46.32 0.0405
2014-05-14 2014-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 182,591 32,893 21.97 12,797 15.22 0.0306
2014-02-14 2013-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 149,698 29,747 24.80 11,107 22.10 0.0289
2013-11-14 2013-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 119,951 114,306 2,024.91 9,097 1,917.07 0.0249
2013-10-10 2013-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 5,645 -18,549 -76.67 451 -66.09 0.0014
2013-08-14 2013-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,645 451
2013-10-10 2013-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 24,194 23,781 5,758.11 1,330 7,723.53 0.0048
2013-05-22 2013-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 25,869 1,422
2013-06-17 2012-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 4,244 -44,400 178 0.0007
2013-10-10 2012-12-31 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 413 -48,231 -99.15 17 -99.38 0.0001
2013-06-21 2012-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 48,644 19,823 2,722 0.0107
2013-10-11 2012-09-30 13F/A-2 VERTEX PHARMACEUTICALS COM 92532F100 48,644 19,823 68.78 2,722 68.86 0.0108
2013-10-11 2012-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 28,821 -353,379 -92.46 1,612 -89.72 0.0073
2013-10-11 2012-03-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 382,200 382,200 15,674 0.0688
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-04-30 2026-03-31 13F VERTEX PHARMACEUTICALS COM Call 6,100 -61.15 2,723 -61.81 n/a n/a n/a
2026-03-20 2025-12-31 13F/A VERTEX PHARMACEUTICALS COM Call 15,700 0.00 7,127 16.07 n/a n/a n/a
2026-03-06 2025-12-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 n/a n/a n/a
2025-11-13 2025-09-30 13F VERTEX PHARMACEUTICALS COM Call 15,700 5.37 6,140 -7.35 n/a n/a n/a
2025-08-13 2025-06-30 13F VERTEX PHARMACEUTICALS COM Call 14,900 39.25 6,627 28.13 n/a n/a n/a
2025-05-14 2025-03-31 13F VERTEX PHARMACEUTICALS COM Call 10,700 -10.08 5,172 8.02 n/a n/a n/a
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM Call 11,900 5.31 4,789 -8.82 n/a n/a n/a
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM Call 11,300 -63.43 5,251 -64.06 n/a n/a n/a
2024-08-12 2024-06-30 13F VERTEX PHARMACEUTICALS COM Call 30,900 -17.38 14,610 -6.54 n/a n/a n/a
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM Call 37,400 63.32 15,634 67.56 n/a n/a n/a
2024-02-12 2023-12-31 13F VERTEX PHARMACEUTICALS COM Call 22,900 -37.77 9,330 -27.76 n/a n/a n/a
2023-11-13 2023-09-30 13F VERTEX PHARMACEUTICALS COM Call 36,800 106.74 12,915 107.10 n/a n/a n/a
2023-08-11 2023-06-30 13F VERTEX PHARMACEUTICALS COM Call 17,800 -35.27 6,236 -27.61 n/a n/a n/a
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Call 27,500 -8.03 8,616 0.77 n/a n/a n/a
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM Call 29,900 15.89 8,550 13.73 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Call 25,800 27.09 7,517 31.19 n/a n/a n/a
2022-08-11 2022-06-30 13F VERTEX PHARMACEUTICALS COM Call 20,300 238.33 5,730 265.90 n/a n/a n/a
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM Call 6,000 -72.22 1,566 -67.14 n/a n/a n/a
2022-02-11 2021-12-31 13F VERTEX PHARMACEUTICALS COM Call 21,600 72.80 4,765 109.17 n/a n/a n/a
2021-11-12 2021-09-30 13F VERTEX PHARMACEUTICALS COM Call 12,500 220.51 2,278 189.82 n/a n/a n/a
2021-08-13 2021-06-30 13F VERTEX PHARMACEUTICALS COM Call 3,900 30.00 786 21.86 n/a n/a n/a
2021-05-14 2021-03-31 13F VERTEX PHARMACEUTICALS COM Call 3,000 -28.57 645 -34.65 n/a n/a n/a
2021-02-25 2020-12-31 13F/A VERTEX PHARMACEUTICALS COM Call 4,200 -78.12 987 -81.16 n/a n/a n/a
2020-11-12 2020-09-30 13F VERTEX PHARMACEUTICALS COM Call 19,200 -32.87 5,240 -36.89 n/a n/a n/a
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM Call 28,600 -58.49 8,303 -49.14 n/a n/a n/a
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM Call 68,900 -10.75 16,326 -2.84 n/a n/a n/a
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM Call 77,200 480.45 16,803 645.81 n/a n/a n/a
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS COM Call 13,300 1,230.00 2,253 1,131.15 n/a n/a n/a
2019-08-13 2019-06-30 13F VERTEX PHARMACEUTICALS COM Call 1,000 183 n/a n/a n/a
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-13 2018-12-31 13F VERTEX PHARMACEUTICALS COM Call 5,400 0.00 895 -14.02 n/a n/a n/a
2018-11-13 2018-09-30 13F VERTEX PHARMACEUTICALS COM Call 5,400 0.00 1,041 13.40 n/a n/a n/a
2018-08-10 2018-06-30 13F VERTEX PHARMACEUTICALS COM Call 5,400 0.00 918 4.32 n/a n/a n/a
2018-05-11 2018-03-31 13F VERTEX PHARMACEUTICALS COM Call 5,400 880 n/a n/a n/a
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM Call 15,400 2,341 n/a n/a n/a
2016-05-13 2016-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS COM Call 11,000 23.69 1,384 94.38 n/a n/a n/a
2013-11-14 2013-09-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-10-10 2013-06-30 13F/A VERTEX PHARMACEUTICALS COM Call 8,893 712 n/a n/a n/a
2013-08-14 2013-06-30 13F VERTEX PHARMACEUTICALS COM Call 8,893 712 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-04-30 2026-03-31 13F VERTEX PHARMACEUTICALS COM Put 6,400 -47.97 2,856 -48.99 n/a n/a n/a
2026-03-20 2025-12-31 13F/A VERTEX PHARMACEUTICALS COM Put 12,300 0.82 5,600 17.70 n/a n/a n/a
2026-03-06 2025-12-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 n/a n/a n/a
2025-11-13 2025-09-30 13F VERTEX PHARMACEUTICALS COM Put 12,200 3.39 4,757 -9.27 n/a n/a n/a
2025-08-13 2025-06-30 13F VERTEX PHARMACEUTICALS COM Put 11,800 -10.61 5,244 -16.87 n/a n/a n/a
2025-05-14 2025-03-31 13F VERTEX PHARMACEUTICALS COM Put 13,200 -27.87 6,307 -14.25 n/a n/a n/a
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM Put 18,300 8.93 7,356 -5.68 n/a n/a n/a
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM Put 16,800 0.00 7,798 -2.34 n/a n/a n/a
2024-08-12 2024-06-30 13F VERTEX PHARMACEUTICALS COM Put 16,800 -59.02 7,985 -53.41 n/a n/a n/a
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM Put 41,000 -12.77 17,138 -10.54 n/a n/a n/a
2024-02-12 2023-12-31 13F VERTEX PHARMACEUTICALS COM Put 47,000 1.73 19,157 18.92 n/a n/a n/a
2023-11-13 2023-09-30 13F VERTEX PHARMACEUTICALS COM Put 46,200 50.98 16,109 49.91 n/a n/a n/a
2023-08-11 2023-06-30 13F VERTEX PHARMACEUTICALS COM Put 30,600 -5.85 10,746 5.29 n/a n/a n/a
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Put 32,500 190.18 10,207 219.64 n/a n/a n/a
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM Put 11,200 -9.68 3,194 -11.70 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Put 12,400 148.00 3,616 155.37 n/a n/a n/a
2022-08-11 2022-06-30 13F VERTEX PHARMACEUTICALS COM Put 5,000 1,416 n/a n/a n/a
2021-05-14 2021-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-25 2020-12-31 13F/A VERTEX PHARMACEUTICALS COM Put 25,700 14.73 5,952 -2.70 n/a n/a n/a
2020-11-12 2020-09-30 13F VERTEX PHARMACEUTICALS COM Put 22,400 -4.27 6,117 -9.95 n/a n/a n/a
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM Put 23,400 16.42 6,793 42.62 n/a n/a n/a
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM Put 20,100 -92.53 4,763 -91.87 n/a n/a n/a
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM Put 269,100 -31.53 58,572 -12.03 n/a n/a n/a
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS COM Put 393,000 1.84 66,582 -5.91 n/a n/a n/a
2019-08-13 2019-06-30 13F VERTEX PHARMACEUTICALS COM Put 385,900 70,766 n/a n/a n/a
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-13 2018-12-31 13F VERTEX PHARMACEUTICALS COM Put 15,400 0.00 2,552 -14.02 n/a n/a n/a
2018-11-13 2018-09-30 13F VERTEX PHARMACEUTICALS COM Put 15,400 -8.33 2,968 3.96 n/a n/a n/a
2018-08-10 2018-06-30 13F VERTEX PHARMACEUTICALS COM Put 16,800 0.00 2,855 4.27 n/a n/a n/a
2018-05-11 2018-03-31 13F VERTEX PHARMACEUTICALS COM Put 16,800 2,738 n/a n/a n/a
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM Put 16,200 2,463 n/a n/a n/a
2016-08-12 2016-06-30 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-13 2016-03-31 13F VERTEX PHARMACEUTICALS COM Put 500 -98.67 40 -99.15 n/a n/a n/a
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS COM Put 37,500 4,719 n/a n/a n/a
2015-08-13 2015-06-30 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-05-14 2015-03-31 13F VERTEX PHARMACEUTICALS COM Put 27,500 0.00 3,244 -0.70 n/a n/a n/a
2015-02-13 2014-12-31 13F VERTEX PHARMACEUTICALS COM Put 27,500 3,267 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.